mFPdmweLKsiPQqGxmR |
OfLyKXWLmcBOcAlMcW [2020-06-12] |
A First Class stamp http://beegteen.site/vek-lexmond/ sextind The Basel-based group noted that the approval makes Erivedge, a capsule taken once-a-day, the first licensed medicine for patients in the European Union "with this disfiguring and potentially life-threatening form of skin cancer". Chief medical officer Hal Barron said the green light "is great news for patients with advanced basal cell carcinoma, who previously had no medicines to treat their disease", adding that Erivedge substantially reduced tumour size in patients in clinical trials.
|
|
|